Promic

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Promic - overview

Established

1999

Location

-, -, Australia

Primary Industry

Pharmaceuticals

About

Promic is a company specializing in the sale and leasing of premium domain names, facilitating online identity acquisition for businesses and individuals. Founded in 1999, Promic operates in Melbourne, Australia, focusing on domain name transactions. The company completed its most recent deal with Oxford Technology 3 VCT in November 2002, securing financing. Promic has successfully executed 2 deals over its history.


Prolysis. com specializes in the sale and leasing of premium domain names, providing an accessible platform for individuals and businesses seeking to secure key online identities. The company's core product offerings include the option to purchase domain names outright or engage in a lease-to-own arrangement, which enables customers to make manageable monthly payments while retaining the option to acquire the domain in full. This service is designed to address the growing need for businesses to establish a recognizable online presence, thereby solving issues related to brand visibility and market accessibility.


Prolysis. com caters to a diverse clientele, including startups, established companies, and entrepreneurs across various industries, primarily targeting markets in North America, Europe, and Asia. The platform simplifies domain transactions by ensuring secure payment processes and providing customer support, reinforcing its commitment to hassle-free user experiences. Prolysis.


com generates revenue through the direct sale of domain names and lease-to-own agreements. Customers can choose to pay a one-time fee or opt for a monthly payment plan, with current offerings prominently including a purchase price of USD 3,888 or a lease option at USD 324 per month. This dual-pricing structure allows for flexibility in customer transactions, appealing to both businesses and individual clients looking to manage their budgets effectively. The transaction process is streamlined, featuring secure payments and local currency options for international clients, enhancing the overall customer experience.


Revenue is primarily derived from individual customers, small businesses, and larger enterprises seeking premium domains that offer strategic advantages in digital branding and marketing initiatives. Looking ahead, Promic plans to expand its offerings with new premium domain names and refine its leasing options to better serve client needs. The company is targeting increased market penetration in North America and Asia by the end of 2023. The funding secured in November 2002 will be utilized to support these initiatives, aimed at enhancing service delivery and operational capacity.


Current Investors

Oxford Technology Management

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.prolysis.com

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Promic - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.